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Aim: The aim of our study was to compare the angiographic changes in 53 nondiabetic
patients, 54 type 2 diabetic patients of less than 5 years of duration, 41 patients with 5–10
years of diabetes, and 27 with more than 10 years of diabetic duration.
Methods: In this cross-sectional study, 175 patients, who underwent coronary angiogram for
the evaluation of the coronary artery disease (CAD), were recruited. Based on the angio-
graphic ﬁndings, syntax score, vessel score, and coronary collaterals grading were analyzed.
The biochemical analysis was done by using the auto analyzer.
Results: A signiﬁcant increase in the mean syntax score ( p = 0.019), vessel score ( p = 0.007),
and coronary collateral grade ( p = 0.008) was observed in the patients with 5–10 years of
diabetes when compared to those with less than 5 years of diabetic duration. There was no
signiﬁcant difference in the mean syntax score ( p = 0.979), vessel score ( p = 0.299), and
collateral grade ( p = 0.842) between the patients with 5–10 years and more than 10 years of
diabetes. The difference in the mean syntax score ( p = 0.791), vessel score ( p = 0.098), and
collateral grade ( p = 0.661) between the nondiabetic and the patients with less than 5 years of
diabetes was not signiﬁcant.
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Conclusion: A signiﬁcant structural change in the coronary arteries was found among the
patients with 5–10 years of diabetes.
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The prevalence of coronary artery disease (CAD) in diabetes is
not only high, but also characterized by severe disease. The
prevalence of CAD in the diabetic population ranges from 9.5%
to 55%,1,2 whereas in the general population, it is reported to be
1.6–4.1%.3,4
There are various conventional risk factors that are known
to be accounted for CAD in both diabetics and nondiabetics.
But in spite of controlling the conventional risk factors, the
burden of CAD is high in the diabetics when compared to
the nondiabetic counterparts. When the diabetic patients have
the CAD, typically they have more severe disease, with more
number of arteries involved, and the higher prevalence of left
main stem disease.5–8
The diabetes being a heterogeneous disease,9 the extent of
CAD is not uniform across the diabetic population. A meta-
analysis of four studies, namely Action to Control Cardiovas-
cular Risk in Diabetes (ACCORD), Action in Diabetes and
Vascular Disease: Preterax and Diamicron Modiﬁed Release
Controlled Evaluation (ADVANCE), United Kingdom Prospec-
tive Diabetes Study (UKPDS), and Veterans Affairs Diabetes
Trial (VADT), have shown that the macrovascular complica-
tions differ with respect to the diabetes duration.10
A large number of analytical scores such as gensini,
syntax, extent, and vessel scores have been developed to
quantify the severity of the coronary atherosclerosis.11 The
severity is said to be a prognostic factor for patients with CAD,
which has been proven in several long-term clinical studies.11
The studies using these analytical scores have shown that the
severity of CAD is high in diabetes when compared to the
nondiabetic population.11 The utility of these scores is not
only restricted to know the progression of atherosclerosis but
also plays an important role in deciding the mode of coronary
interventions.
Since there can be a variation in the CAD outcomes among
the diabetic population of different time intervals, we wanted
to look for the structural changes in coronary arteries with
respect to the different time intervals of type 2 diabetes
mellitus. If we are able to identify the CAD changes in a speciﬁc
time frame of diabetes, it would help us in better management
and prevention of the CAD among the diabetic population.
Ideally, longitudinal study has to be carried out in order to
ﬁnd out the structural changes in the coronary arteries with
respect to the different time intervals of type 2 diabetes
mellitus, but due to the practical inconvenience, a cross-
sectional study was designed to compare the severity of the
CAD, number of vessels involved in the lesion, coronary
collateral grade, and urine microalbumin levels in nondiabetic
population, in diabetic population with less than 5 years, in
5–10 years, and more than 10 years of diabetes duration.2. Methods
This was a cross-sectional study of 175 patients who
underwent coronary angiogram for the evaluation of CAD at
a tertiary care hospital from February 2013 to December 2013.
The patients were recruited in the study after obtaining an
informed consent. In order to maintain the homogeneity
among the groups and to minimize the effect of confounders,
the age of the study population was restricted to 45–65 years.
The patients were further grouped into diabetics and
nondiabetics based on the diagnostic criteria recommended
by the American diabetes association.12 The patients with
congenital heart disease, valvular heart disease, and those
with signiﬁcant thyroid, renal dysfunction were excluded from
the study. The study was conducted after obtaining the
approval from institutional human ethics committee.
The fasting blood sugar, fasting lipid proﬁle and glycated
hemoglobin levels and urine microalbumin were measured at
the time of admission. The biochemical analysis was done by
using the auto analyzer Hitachi P800. The coefﬁcient of variation
was <2% and <5% for intra- and inter-batch assay, respectively,
in all the cases. The presence of coronary collaterals was
visualized and identiﬁed after the coronary angiography and it
was deﬁned as Rentrop score ≥1.13 The number of vessels
involved in the lesion were assessed by vessel score.14 Only
those vessels with 70% stenosis or greater reduction in luminal
diameter were considered to be signiﬁcant. The left main artery
stenosis was scored as single vessel disease. The number of
vessels involved in the lesion ranged from 0 to 3. The severity
and the extent of the CAD were assessed by the syntax score,15
which is a web-based algorithm consisting sequential and
interactive self-guided questions. The syntax score, vessel
score, presence of coronary collaterals and the grading were
carried out by a cardiologist, who was blind to other parameters.
2.1. Statistical analysis
The data were represented as mean  standard deviation. The
Analysis of Variance (ANOVA) was performed in order to
identify the differences in the mean syntax score, vessel score,
coronary collaterals and urine microalbumin between the
groups. The post-hoc analysis was done assuming the equality
of variances. The least square difference (LSD) post-hoc test
was performed to ﬁnd out the signiﬁcant differences in the
mean syntax score, vessel score, coronary collateral grading,
and microalbumin levels between the nondiabetic, diabetes
with less than 5 years duration, 5–10 years of diabetes, and
more than 10 years of diabetic duration. p value <0.05 was
considered to be signiﬁcant. The data were analyzed using the
statistical package for social sciences (SPSS) version 16 (SPSS,
Chicago, IL, USA).














F p value p value
trend
Syntax score 12.28  6.63 12.77  8.82 17.48  11.09 17.42  13.23 3.65 0.014 0.003
Collateral score 0.35  0.81 0.277  0.81 0.80  1.10 0.85  1.19 3.99 0.009 0.004
Vessel score 1.32  0.75 1.61  0.81 2.12  1.00 1.89  1.15 6.65 <0.001 <0.001
Microalbumin 19.08  30.49 36.72  61.91 39.55  70.94 81.21  136.73 4.16 0.007 0.001














Fasting blood sugar 98.71  7.85 168.77  52.73 194.80  60.51 203.07  64.96
TC-HDL ratio 4.39  1.24 4.48  1.67 4.25  1.57 4.05  1.43
LDL 119.82  44.87 103.24  49.82 89.43  36.59 94.87  42.28
Triglycerides 111.52  52.65 148.47  77.16 151.21  91.44 137.07  55.91
HbA1C 5.67  0.37 8.29  1.95 9.47  1.83 9.39  1.36
TC-HDL ratio, total cholesterol-high density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; HbA1c, glycated hemoglobin.
Fig. 1 – Graph showing the difference in mean syntax score
between nondiabetes and different time intervals of type 2
diabetes mellitus. *Represents the mean difference is
significant at the level of 0.05 with in the groups.
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In a total of 175 subjects who were recruited in this study, 53
were nondiabetics, and 122 were found to be having a history
of type 2 diabetes mellitus. Further, based on the duration of
diabetes the type 2 diabetic population was further subdivided.
Among them, 54 were with less than 5 years, 41 were with 5–10
years, and 27 were with more than 10 years of diabetes
duration.
The clinical and angiographic characteristics of the study
population are shown in Table 1. The mean age of the study
population was 56.47  5.89. The mean syntax score, vessel
score, collateral grade, and microalbumin were high in
patients with more than 5 years of diabetes compared to less
than 5 years of diabetes and nondiabetes as shown in Table 1.
The mean diabetic duration was 2.62  1.48 in less than 5
years of diabetes, 8.02  1.73 in 5–10 years of diabetes, and
17.14  3.99 in more than 10 years of diabetes. Among overall
175 subjects, 80 (46%) of them were found to be having the
history of hypertension. Among the 53 nondiabetics, 17
(32.1%) of them had hypertension. The presence of hyperten-
sion was seen in 29 (52.8%) out of 54 with less than 5 years of
diabetes, 22 (53.7%) out of 41 with 5–10 years, and 13 (48.1%)
out of 27 with more than 10 years of diabetic duration. The
biochemical characteristics of the study population are
shown in Table 2.
One-way ANOVA showed a signiﬁcant difference between
the groups with respect to syntax score ( p = 0.014), coronary
collateral grade ( p = 0.009), urine microalbumin ( p = 0.007),
and vessel score ( p < 0.001). Further post-hoc analysis with
LSD showed a signiﬁcance difference in the mean syntax
score, collateral grade, vessel score, and urine microalbumin
within the groups.
A signiﬁcant difference with respect to syntax score
( p = 0.019) (Fig. 1), vessel score ( p = 0.007) (Fig. 2), and collateralgrade ( p = 0.008) (Fig. 3) was observed between less than 5
years of type 2 diabetes mellitus and 5–10 years of type 2
diabetes mellitus. A signiﬁcant difference in urine micro-
albumin was observed only in more than 10 years of diabetes
mellitus ( p = 0.025) (Fig. 4) when compared with 5–10 years of
diabetes mellitus. There was no signiﬁcant difference in mean
syntax score ( p = 0.979) (Fig. 1), vessel score ( p = 0.299) (Fig. 2),
and collateral grade ( p = 0.842) (Fig. 3) between 5 and 10 years
of type 2 diabetes mellitus and more than 10 years of type 2
diabetes mellitus. There was no signiﬁcant difference ob-
served in the mean syntax score ( p = 0.791) (Fig. 1), vessel score
( p = 0.098) (Fig. 2), collateral grade ( p = 0.661) (Fig. 3), and urine
microalbumin ( p = 0.217) (Fig. 4) between nondiabetics and
less than 5 years of type 2 diabetes mellitus.
Fig. 2 – Graph showing the difference in mean vessel score
between nondiabetes and different time intervals of type 2
diabetes mellitus. *Represents the mean difference is
significant at the level of 0.05 with in the groups.
Fig. 3 – Graph showing the difference in mean collateral
grade between nondiabetes and different time intervals of
type 2 diabetes mellitus. *Represents the mean difference
is significant at the level of 0.05 with in the groups.
Fig. 4 – Graph showing the difference in mean urine
microalbumin between nondiabetes and different time
intervals of type 2 diabetes mellitus. *Represents the mean
difference is significant at the level of 0.05 with in the
groups.
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In the present study, we compared the angiographic patterns
of the coronary artery disease in the nondiabetics, the
diabetics with less than 5 years, 5–10 years, and more than
10 years of duration. We noticed the signiﬁcant structural
changes in the coronary arteries in the patients with more
than 5 years of type 2 diabetes mellitus.
The proﬁle and complications of the CAD are not uniform
among the diabetic population. The studies have shown that
the spectra of the CAD differ with respect to the different time
intervals of type 2 diabetes mellitus.10 Even in the United
Kingdom Prospective Diabetes study risk engine, events less
than 4 years were not considered while forming the risk
score.16Earlier studies suggested that the diabetic patients had poor
collaterals formation17; however, later studies have shown
that collateral formation is independent of diabetes mellitus
and depends on the degree of the coronary artery stenosis.18 In
our study, we observed that the presence of coronary
collaterals is directly proportional to the severity of the
CAD. Thus, the presence of collaterals was seen only in more
than 5 years of diabetes as syntax score was high in this group
compared to nondiabetes and less than 5 years of diabetes.
In the current study, a signiﬁcant increase in the mean
syntax score, vessel score, and coronary collateral grade was
observed between 5 and 10 years of diabetic duration when
compared to less than 5 years of diabetes, whereas the
difference in the mean syntax score, vessel score, and
coronary collateral grade both in the nondiabetics and less
than 5 years of diabetes, 5–10 years, and more than 10 years of
diabetes was not signiﬁcant. The observation from the present
study indicates that the coronary proﬁle between the
nondiabetic group and the less than 5 years of diabetes could
be similar and a chronic severe structural narrowing of
coronary artery takes place in 5–10 years of type 2 diabetes
mellitus. Beyond 10 years, we visually noticed a plateau trend
with no further morphological changes in the coronary
arteries.
In the present study, a signiﬁcant difference in the urine
microalbumin is observed in more than 10 years of diabetes.
Even though the microvascular changes are set in at initial
stages of diabetes, their progression is signiﬁcant only after10
years as pointed by our result. But the macrovascular changes
are time-dependent, getting established between 5 and 10
years of diabetes. Our study also shows that there is no
signiﬁcant correlation between the urine microalbumin and
the syntax score (r = 0.11, p = 0.125), vessel score (r = 0.10,
p = 0.143), and collateral grading (r = 0.15, p = 0.095).
The prevalence of microvascular complications increases
with the duration of the diabetes.19 A recent study has showed
that the incidence of microvascular outcomes is higher after 10
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whereas the cardiovascular complications seem to be appear-
ing before 10 years of diabetes.20 Type 2 diabetes mellitus with
more than 5 years of duration have quantitative and
qualitative, severe vascular disease compared to less than 5
years of diabetes. This raises the interesting possibility of
insulin resistance in generation of macrovascular complica-
tions in type 2 diabetes mellitus. Hyper insulinemia brings
about both functional and structural changes in the blood
vessels. Functional changes are mediated through nitric oxide
by receptor-mediated resistance and maintain the vasodilata-
tion. But the structural changes occur by proatherogenic
response mediated by MAP kinase pathway, which is not
affected by IR. The continuous action of hyper insulin through
the MAP kinase pathway results in a signiﬁcant structural
change over a period of time.21 The peak effect of hyper
insulinemia and insulin resistance probably appears from 4 to
5 years of diabetes mellitus and thus resulting in increased
severity of the CAD between ﬁve and 10 years of diabetes.
Our study conﬁrms that the extent and the degree of the
CAD are similar both in nondiabetics and diabetes with less
than 5 years. They are often present with discrete lesions, less
severe disease, and involvement of single vessel. However, the
structural changes in the coronary arteries were observed in
more than 5 years of diabetes with diffused, long segment and
multi vessel stenosis, a characteristic feature of a typical
diabetic coronary artery disease. It is likely that most of the
patients with type 2 diabetes mellitus with less than 5 years of
duration might be suitable candidates for angioplasty,
whereas candidates with more than 5 years of diabetes may
be suitable for coronary artery bypass graft (CABG).
The microvascular beneﬁts can be seen even in the longer
duration of diabetes but macrovascular beneﬁts are restricted
to the initial 5 years of type 2 diabetes mellitus. Thus, the
potential window of opportunity for modifying the macro-
vascular complications is restricted to 0–5 years because
beyond 5 years the severe irreversible structural modiﬁcations
are observed.
Even the previous UKPDS studies have shown that intense
therapeutic interventions have reduced the macrovascular
complications in less than 5 years of diabetes.5 Thus, in
general, the diabetic population intense therapeutic interven-
tions are to be considered within 5 years to reduce the
cardiovascular complications.
Individual variations are seen in diabetes complications but
our study showed that the variations with respect to the speciﬁc
time intervals need to be considered. There appears to be a
threshold period of 5–10 years, beyond which the CAD appears.
The limitation of the study is the cross-sectional design.
The coronary collaterals have been assessed by angiographic
images. Further classiﬁcation of patients based on major
adverse cardiac events might give us a better insight to
compare the coronary patterns between the different groups.
5. Conclusion
Based on the limitations, the study highlights that the
structural changes in the coronary arteries have been observed
in more than 5 years of diabetes. The coronary patterns aresimilar among the nondiabetics and in those with less than 5
years of diabetes. Similarly, the coronary proﬁle between 5 and
10 years and more than 10 years of diabetes is same. This
emphasizes that the irreversible cardiovascular damage has
already occurred between 5 and 10 years of diabetes and there
is no scope for interventions beyond 10 years. Thus, there is a
need to target the intense therapeutic intervention within 5
years of type 2 diabetes mellitus.
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